Resources

Your selections:

Clear all

Show Filters

We found 280 resources that match your search.

10-1074-LS(-J)

Document Date:

16055 NFL Delta Gly4 Env Protein Trimer, Adjuvanted with 3M-052 AF + Alum

Document Date:

2020 IND Lists of Studies having CRF/Pharmacy Records That Will Not be Stored by DAIDS

Document Date:

2020 non-IND Lists of Studies having CRF/Pharmacy Records That Will Not be Stored by DAIDS

Document Date:

3BNC117-LS (-J)

Document Date:

3M-052-AF

Document Date:

426c.Mod.Core-C4b, Adjuvanted

Document Date:

Abacavir Sulfate (Ziagen) Risk List

The following side effects have been associated with the use of abacavir:

Document Date:

Abacavir Sulfate/Dolutegravir/Lamivudine (Triumeq) Package Insert

Document Date:

Abacavir/Lamivudine (Epzicom) Package Insert

Document Date:

ABT-267, ABT 333, ABT-450 and Ritonavir

Document Date:

Accessing and Maintaining Site Personnel Information in the DAIDS-ES

Tutorial guide, with screenshots, for the DAIDS-ES system.

Document Date:

ACTG - Expedited Reporting to DAIDS and DAERS Refresher

Presentation on expedited reporting to DAIDS plus a case study on expedited reporting via DAERS.

Document Date:

ACTG IND Study Financial Disclosure Form Template

ACTG IND study financial disclosure form template.

Document Date:

Addendum 1, Female Genital Grading Table for Use in Microbicide Studies

Guidance table for grading the severity of adult and pediatric adverse events with female genital involvement during microbicide studies.

Document Date:

Addendum 2 Male Genital Grading Table for Use in Microbicide Studies

Guidance table for grading the severity of adult and pediatric adverse events with male genital involvement during microbicide studies.

Document Date:

Addendum 3 Rectal Grading Table for Use in Microbicide Studies (Clarification dated May 2012)

Guidance table for grading the severity of adult and pediatric adverse events with rectal involvement during microbicide studies.

Document Date:

Algorithm for Determining Whether Site Specific Informed Consent Forms will be Reviewed at the Time of Initial Protocol Registration

Document Date:

Azithromycin Package Insert

Document Date:

B63521^11 gp120

BCG Vaccine

Document Date:

Bedaquiline (Sirturo) Package Insert

SIRTURO is a diarylquinoline antimycobacterial drug indicated as part of combination therapy in adults (18 years and older) with pulmonary multi-drug resistant tuberculosis (MDR-TB). Reserve SIRTURO for use when an effective treatment regimen cannot otherwise be provided. Administer SIRTURO by…

Document Date:

BG505 SOSIP.664 gp140, Adjuvanted with 3M-052-AF + Alum, or CpG 1018 + Alum, or GLA-LSQ, or Alum

Document Date:

BG505 SOSIP.GT1.1 gp140 Vaccine

Document Date:

Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy) Package Insert

Document Date: